Federal Register #FDA2026N0496

FDA Requests Public Comments on CGMP Information Collection for Medicated Feeds

This opportunity involves a request for public comments by the Food and Drug Administration (FDA), under the Department of Health and Human Services, regarding information collection for current good manufacturing practice (CGMP) regulations for Type A medicated articles and medicated feeds. - Government Buyer: - Food and Drug Administration (FDA), Department of Health and Human Services - OEMs and Vendors: - No OEMs or vendors are specified in this notice - Products/Services Requested: - Written public comments and recommendations on CGMP regulations for Type A medicated articles and medicated feeds - Focus on information collection activities, including recordkeeping and quality control procedures for manufacturers, commercial feed mills, licensed mixer/feeders, and manufacturers of Type A medicated articles - Unique or Notable Requirements: - Requirements pertain to maintaining records on manufacturing processes, laboratory controls, packaging, labeling, batch production, distribution, and complaint files - No procurement of products or services, part numbers, or quantities are specified - This is a request for information and comments, not a solicitation for goods or services

Description

The Food and Drug Administration (FDA) is announcing a proposed collection of information submitted to the Office of Management and Budget (OMB) for review under the Paperwork Reduction Act of 1995. The collection supports current good manufacturing practices (CGMPs) for Type A medicated articles and medicated feeds, including recordkeeping and quality control procedures. The FDA seeks written comments on this information collection by July 20, 2026. This effort aims to ensure compliance with the Federal Food, Drug, and Cosmetic Act regarding safety, identity, strength, quality, and purity of medicated feeds and articles.

View original listing